摘要
近年来,全球医药产业规模虽不断扩大,但增速明显放缓。全球市场新药上市数目趋于下行,新药市场占有率每况愈下,加之专利药物集中过期,未来全球新药市场将向哪里发展?该文从新药研发成功率、欧美新药审批情况等多方面对新药发展情况进行了剖析,并对未来新药发展方向进行了预测。
In recent years, the global medicine market keeps on expanding, but the growth rate is slowing down significantly. The number of global new drug launches is falling down and the market share of new drugs remains low in these years. With the patent cliff on the horizon, what will happen in global pharmaceutical market？ This paper analyzes the current status of new drugs from clinical development success rates and drug approvals in Europe and the U. S. , and predicts the development trend for new drugs.
出处
《精细与专用化学品》
CAS
2014年第5期4-8,共5页
Fine and Specialty Chemicals
关键词
新药
研发成本
临床研究成功率
审批
孤儿药
生物医药
new drug
research cost
clinical development success rates
approval
orphan drug
bio-medicine
